Dr. Doucette is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3800 Reservoir Rd NW
Washington, DC 20007Phone+1 202-444-3736Fax+1 202-444-0939
Education & Training
St. George's University School of MedicineClass of 2015
Certifications & Licensure
DC State Medical License 2018 - 2026
MD State Medical License 2021 - 2026
VA State Medical License 2023 - 2026
NJ State Medical License 2024 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Venetoclax-based induction therapy for primary plasma cell leukemia with high BCL-2 expression.Charalampos Charalampous, Kimberley Doucette, Aimee Chappell, David H Vesole
Leukemia & Lymphoma. 2024-12-01 - Post-ASCT consolidation with elotuzumab, lenalidomide, and dexamethasone or elotuzumab, pomalidomide, and dexamethasone in high-risk and ultra-high-risk multiple myelo...Eli Zolotov, Maciej Kabat, Harsh Parmar, Palka Anand, Joshua Zenreich
Leukemia & Lymphoma. 2024-12-01 - Role of Autologous Stem Cell Transplantation in Systemic Light Chain Amyloidosis.Harsh Parmar, Kimberley Doucette, David Vesole
Clinical Lymphoma, Myeloma & Leukemia. 2024-11-01
Press Mentions
Recent Advancements and Future Directions in Frontline Treatment of Multiple MyelomaJuly 11th, 2022
Genetics of Donor Cell Leukemia in Acute Myelogenous Leukemia and Myelodysplastic SyndromeMarch 8th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
